FDA Approves First Nasal Spray for Allergic Reactions

The U.S. Food and Drug Administration has approved ARS Pharmaceuticals’ nasal spray as the first needle-free emergency treatment for potentially fatal allergic reactions, the regulator said on Friday. Shares of ARS Pharmaceuticals rose nearly 9% on the news. The spray, which…[#item_full_content]

Related articles

You may also be interested in

Headline

Never Miss A Story

Get our Weekly recap with the latest news, articles and resources.
Cookie policy

We use our own and third party cookies to allow us to understand how the site is used and to support our marketing campaigns.